| Cat. No. |
Product Name |
Information |
| PC-60754 |
CV-6209
PAF inhibitor
|
CV-6209 is a highly potent, selective platelet activating factor (PAF) inhibitor with IC50 of 75 and 170 nM for aggregation inhibition of rabbit and human platelets induced by PAF. |
| PC-70117 |
TCV-309
PAF inhibitor
|
TCV-309 is a highly potent and selective platelet activating factor (PAF) antagonist, inhibits PAF-induced aggregation of rabbit and human platelets with IC50s of 33 nM and 55 nM respectively. |
| PC-70046 |
Israpafant
PAF antagonist
|
Israpafant (Y24180) is a specific antagonist of PAF receptor that inhibits PAF-induced rabbit platelet aggregation in vitro (IC50=3.84 nM), with little effect on adenosine diphosphate- or arachidonic acid-induced aggregation. |
| PC-70045 |
Apafant
PAF antagonist
|
Apafant (WEB2086) is a potent and specific antagonist of platelet activating factor (PAF) receptor that inhibits PAF-induced human platelet and neutrophil aggregation in vitro with IC50 of 0.17 and 0.36 uM, respectively. |
| PC-45596 |
TCV-309 chloride
PAF inhibitor
|
TCV-309 chloride is a highly potent and selective platelet activating factor (PAF) antagonist, inhibits PAF-induced aggregation of rabbit and human platelets with IC50s of 33 nM and 55 nM respectively. |
